Thyrocare Technologies Limited (BOM:539871)
565.50
-1.70 (-0.30%)
At close: Aug 21, 2026
Thyrocare Technologies Revenue
Thyrocare Technologies had revenue of 2.40B INR in the quarter ending June 30, 2026, with 24.34% growth. This brings the company's revenue in the last twelve months to 8.76B, up 21.09% year-over-year. In the fiscal year ending March 31, 2026, Thyrocare Technologies had annual revenue of 8.29B with 20.61% growth.
Revenue (ttm)
8.76B
Revenue Growth
+21.09%
P/S Ratio
10.27
Revenue / Employee
4.60M
Employees
1,906
Market Cap
90.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.29B | 1.42B | 20.61% |
| Mar 31, 2025 | 6.87B | 1.15B | 20.19% |
| Mar 31, 2024 | 5.72B | 452.20M | 8.59% |
| Mar 31, 2023 | 5.27B | -621.90M | -10.56% |
| Mar 31, 2022 | 5.89B | 942.40M | 19.05% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 841.37M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |
| Clinitech Laboratory | 94.91M |
Thyrocare Technologies News
- 2 months ago - Thyrocare Technologies announces Rs 7 per share final dividend for FY26 - Business Upturn
- 2 months ago - Thyrocare Technologies announces 26th AGM on June 30, 2026 - Business Upturn
- 2 months ago - Thyrocare Technologies reports 98.66% turnover from diagnostic services in FY 2025-26 - Business Upturn
- 3 months ago - Thyrocare shares jump over 11% after Q4 results; Net profit surges 117% to Rs 47.1 crore, revenue up 19.7% - Business Upturn
- 5 months ago - Thyrocare Technologies receives Rs 2 crore tax demand notice for FY 2024-25 - Business Upturn
- 7 months ago - Thyrocare Technologies shares fall sharply over 4% today despite strong Q3 FY26 results - Business Upturn
- 11 months ago - Thyrocare shares jump over 11% after strong Q2 results; Approves bonus issue in 2:1 ratio - Business Upturn
- 11 months ago - Thyrocare Technologies Q2 Results: Revenue soars 22% YoY to Rs 216.5 crore, net profit up 79% - Business Upturn